Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kern

Showing results (231-240 of 397) with videos related to

Pageof 40
Sort By:
The Journal of Antimicrobial Chemotherapy|March 15, 2006
Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamideStefanie Pannek, Paul G Higgins, Petra Steinke, et al.
Emerging Infectious Diseases|June 15, 2013
Human infection with marten tapewormPhilipp Eberwein, Alexandra Haeupler, Fabian Kuepper, et al.
Annals of Hematology|January 1, 1994
Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropeniaB Hertenstein, W V Kern, T Schmeiser, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2016
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux AssayJürgen A Bohnert, Sabine Schuster, Winfried V Kern, et al.
Infection|June 28, 2018
Onset of symptoms, diagnostic confirmation, and occurrence of multiple infective foci in patients with Staphylococcus aureus bloodstream infection: a look into the order of events and potential clinical implicationsJesper Smit, Siegbert R Rieg, Andreas F Wendel, et al.
Microbiology Spectrum|October 13, 2025
Frequent high-level rifaximin resistance in <i>Escherichia coli</i> associated with long-term treatment of patients with liver cirrhosis: a prospective, controlled studyL Boll, W V Kern, S Schuster, et al.
BMC Medicine|February 7, 2025
High risk for life-threatening adverse events of fluoroquinolones in young adults: a large German population-based cohort studyJulia Wicherski, Jonas Peltner, Cornelia Becker, et al.
Deutsche Medizinische Wochenschrift (1946)|November 29, 2024
[Antibiotic prescribing trends in German acute care hospitals from 2012/13 through 2021/22]Winfried V Kern, Michaela Steib-Bauert, Matthias Fellhauer, et al.
Trials|February 14, 2020
Protocol update for the SABATO trial: a randomized controlled trial to assess early oral switch therapy in low-risk Staphylococcus aureus bloodstream infectionAchim J Kaasch, Anna Rommerskirchen, Martin Hellmich, et al.
Emergency Medicine Journal : EMJ|September 28, 2014
Implementation of an intensified antibiotic stewardship programme targeting third-generation cephalosporin and fluoroquinolone use in an emergency medicine departmentJohannes P Borde, Winfried V Kern, Martin Hug, et al.
Pageof 40

Showing results (231-240 of 397) with videos related to

Sort By:
Pageof 40
The Journal of Antimicrobial Chemotherapy|March 15, 2006
Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamideStefanie Pannek, Paul G Higgins, Petra Steinke, et al.
Emerging Infectious Diseases|June 15, 2013
Human infection with marten tapewormPhilipp Eberwein, Alexandra Haeupler, Fabian Kuepper, et al.
Annals of Hematology|January 1, 1994
Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropeniaB Hertenstein, W V Kern, T Schmeiser, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2016
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux AssayJürgen A Bohnert, Sabine Schuster, Winfried V Kern, et al.
Infection|June 28, 2018
Onset of symptoms, diagnostic confirmation, and occurrence of multiple infective foci in patients with Staphylococcus aureus bloodstream infection: a look into the order of events and potential clinical implicationsJesper Smit, Siegbert R Rieg, Andreas F Wendel, et al.
Microbiology Spectrum|October 13, 2025
Frequent high-level rifaximin resistance in <i>Escherichia coli</i> associated with long-term treatment of patients with liver cirrhosis: a prospective, controlled studyL Boll, W V Kern, S Schuster, et al.
BMC Medicine|February 7, 2025
High risk for life-threatening adverse events of fluoroquinolones in young adults: a large German population-based cohort studyJulia Wicherski, Jonas Peltner, Cornelia Becker, et al.
Deutsche Medizinische Wochenschrift (1946)|November 29, 2024
[Antibiotic prescribing trends in German acute care hospitals from 2012/13 through 2021/22]Winfried V Kern, Michaela Steib-Bauert, Matthias Fellhauer, et al.
Trials|February 14, 2020
Protocol update for the SABATO trial: a randomized controlled trial to assess early oral switch therapy in low-risk Staphylococcus aureus bloodstream infectionAchim J Kaasch, Anna Rommerskirchen, Martin Hellmich, et al.
Emergency Medicine Journal : EMJ|September 28, 2014
Implementation of an intensified antibiotic stewardship programme targeting third-generation cephalosporin and fluoroquinolone use in an emergency medicine departmentJohannes P Borde, Winfried V Kern, Martin Hug, et al.
Pageof 40